STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Natera, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Natera, Inc. (NTRA) notice reports a proposed sale of 10,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,800,000. The filing lists 137,248,106 shares outstanding, so the block represents about 0.0073% of outstanding stock, indicating a very small ownership fraction being sold. The shares were acquired as a gift on 03/02/2020 from the issuer, and the filing discloses two recent sales in the past three months: 5,000 shares sold on 09/12/2025 for $852,707 and 1,718 shares sold on 07/28/2025 for $240,190.65. The filer certifies they are not aware of any undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Proposed sale is immaterial to market capitalization but shows continued insider/affiliate dispositions.

The notice documents a planned disposition of 10,000 common shares valued at $1.8 million via a major broker, representing approximately 0.0073% of issued shares. Recent dispositions of 5,000 and 1,718 shares in the prior three months indicate the filer or related parties have been selling modest tranches rather than liquidating a large position. For investors, these transactions are routine Rule 144 disclosures required when affiliates/insiders sell restricted or control securities; they do not by themselves indicate company performance changes.

TL;DR: Filing appears procedurally complete with broker and acquisition details; includes required representations.

The form includes broker identification, the nature of acquisition (gift from issuer), number of shares outstanding, and recent sales history, plus the filer’s representation of no undisclosed material adverse information. These elements satisfy typical Rule 144 disclosure requirements. Compliance risk appears low based on the disclosed information, though monitoring continued periodic sales is prudent for tracking insider liquidity patterns.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for NTRA report?

The filing reports a proposed sale of 10,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,800,000.

How many NTRA shares are outstanding according to the filing?

The filing lists 137,248,106 shares outstanding.

When and how were the shares being sold acquired?

The 10,000 shares were acquired as a gift from the issuer on 03/02/2020.

Have there been recent sales by the same account?

Yes. The filing discloses sales of 5,000 shares on 09/12/2025 for $852,707.00 and 1,718 shares on 07/28/2025 for $240,190.65.

Does the filing indicate any undisclosed material information?

The filer represents by signature that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

32.73B
133.33M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN